Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Trading Down 4.6% - Should You Sell?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scientific shares declined by 4.6%, trading at $74.53, with a significant drop in trading volume of 67% from the average.
  • Research analysts have lowered ratings on the stock, with HSBC Global Research changing it from a "strong-buy" to a "hold," leading to an average rating of "Hold" across multiple analysts.
  • The company offers a range of analytical testing and laboratory services worldwide, focusing on product safety and authenticity evaluations.
  • MarketBeat previews the top five stocks to own by September 1st.

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) were down 4.6% on Monday . The company traded as low as $74.53 and last traded at $74.53. Approximately 521 shares traded hands during trading, a decline of 67% from the average daily volume of 1,567 shares. The stock had previously closed at $78.10.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Hsbc Global Res lowered Eurofins Scient from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. HSBC cut Eurofins Scient to a "hold" rating in a research note on Friday, April 25th. Finally, Citigroup reiterated a "neutral" rating on shares of Eurofins Scient in a report on Friday, July 25th. Five equities research analysts have rated the stock with a hold rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Eurofins Scient presently has an average rating of "Hold".

Read Our Latest Stock Report on Eurofins Scient

Eurofins Scient Trading Up 0.0%

The firm has a 50 day simple moving average of $70.97 and a 200 day simple moving average of $61.17. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines